eosinophilic esophagitis
FDA Approves First Oral Budesonide for EoE
The FDA approved the first oral suspension of budesonide (Eohilia, Takeda) for patients with eosinophilic ...
FEBRUARY 14, 2024
FDA Approves Dupixent for Pediatric Eosinophilic Esophagitis
The FDA approved Dupixent to treat eosinophilic esophagitis in children ages 1 year and older.
JANUARY 26, 2024
FDA Expands Dupliumab Indication to EoE
Dupliumab is now indicated for the treatment eosinophilic esophagitis in patients 12 years and older weighing more ...
MAY 23, 2022
Load more